LAS VEGAS and VANCOUVER, British Columbia, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE:SO6) (the “Company”), a fast-growing mobile clinical network and medical platform which enables flexible at-home medical services across 50 states in the United States, announces today its intention to make a normal course issuer bid (the "Bid") to purchase for cancellation, from time to time, as it considers advisable, up to 1,378,633 of its issued and outstanding common shares, being approximately 3.42% of the Company's currently outstanding common shares and approximately 10.0% of 13,786,334 which represents the Company's Public Float (as that term is defined in the policies of the TSX Venture Exchange (the "Exchange"). The Bid will commence on October 4, 2024, and will terminate on October 3, 2025, or such earlier time as the Bid is completed or at the option of the Company. Research Capital Corporation of Vancouver, British Columbia will conduct the Bid on behalf of the Company.
